Sehyeon Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sehyeon Park has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Pil Kim
Department of Biotechnology, The Catholic University of Korea, Bucheon 14662, Republic of Korea
5 shared publications - Hyung Kwoun Kim
Department of Biotechnology, The Catholic University of Korea, Bucheon 14662, Republic of Korea
4 shared publications Seungki Lee
Department of Biotechnology, The Catholic University of Korea, Bucheon, Gyeonggi, South Korea
3 shared publications- Min Jeong Cha
Department of Physiology, BK21 Project, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea
2 shared publications Soyeon Lee
Research Group of Novel Food Ingredients for Alternative Proteins, The Catholic University of Korea, Bucheon, Gyeonggi, South Korea
2 shared publicationsTaeyeon Kim
Research Group of Novel Food Ingredients for Alternative Proteins, The Catholic University of Korea, Bucheon, Gyeonggi, South Korea
2 shared publications
Latest Publications
- Open Access
- 4 January 2026
- Published by Wiley in Biotechnology Journal
- Vol. 21 (1) , e70175
A Growth‐Coupled Evolutionary Strategy Enhances Heme Biosynthesis in Saccharomyces cerevisiae
Enhancing the nutritional and sensory qualities of microbial single‐cell proteins (SCPs) requires strategies to increase heme content in edible microorganisms. We adapted the Growth‐Acceleration Targeting Evolution (GATE) platform, initially developed in Corynebacterium glutamicum , for use in Saccharomyces cerevisiae . By engineering a plasmid that connects the heme‐responsive CYC1 promoter to the growth‐promoting PTH1 gene, we established a feedback loop that links intracellular heme levels to accelerated cell proliferation. After 100 h of continuous culture under growth‐selective pressure, we cured out the plasmid to isolate an Evol‐GATE strain. Compared to the parental type, Evol‐GATE displayed a five‐fold increase in intracellular heme, a slight reduction in biomass, and coordinated upregulation of the heme biosynthetic pathway. Transcriptome analysis confirmed increased expression of heme biosynthesis and associated respiratory genes in Evol‐GATE. Whole‐genome sequencing revealed only a small number of dispersed variants, and no residual plasmid sequences, supporting its classification as a non‐GMO mutant. Our results demonstrate that GATE can effectively select yeast mutants with significantly improved heme productivity, providing a promising approach to develop non‐GMO SCPs enriched in heme for next‐generation meat analogues.
- 4 January 2026
- Published by Wiley in Biotechnology Journal
- Vol. 21 (1) , e70175
Open AccessA Growth‐Coupled Evolutionary Strategy Enhances Heme Biosynthesis in Saccharomyces cerevisiae
Enhancing the nutritional and sensory qualities of microbial single‐cell proteins (SCPs) requires strategies to increase heme content in edible microorganisms. We adapted the Growth‐Acceleration Targeting Evolution (GATE) platform, initially developed in Corynebacterium glutamicum , for use in Saccharomyces cerevisiae . By engineering a plasmid that connects the heme‐responsive CYC1 promoter to the growth‐promoting PTH1 gene, we established a feedback loop that links intracellular heme levels to accelerated cell proliferation. After 100 h of continuous culture under growth‐selective pressure, we cured out the plasmid to isolate an Evol‐GATE strain. Compared to the parental type, Evol‐GATE displayed a five‐fold increase in intracellular heme, a slight reduction in biomass, and coordinated upregulation of the heme biosynthetic pathway. Transcriptome analysis confirmed increased expression of heme biosynthesis and associated respiratory genes in Evol‐GATE. Whole‐genome sequencing revealed only a small number of dispersed variants, and no residual plasmid sequences, supporting its classification as a non‐GMO mutant. Our results demonstrate that GATE can effectively select yeast mutants with significantly improved heme productivity, providing a promising approach to develop non‐GMO SCPs enriched in heme for next‐generation meat analogues.
- 16 May 2025
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 189, 110672
Development of functional ricinoleic acid ergosterol ester by Proteus vulgaris K80 lipase-mediated transesterification
- 16 May 2025
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 189, 110672
Development of functional ricinoleic acid ergosterol ester by Proteus vulgaris K80 lipase-mediated transesterification
- Open Access
- 9 October 2024
- Published by Taylor & Francis in CyTA - Journal of Food
- Vol. 22 (1)
Nutritional properties of pilot-scale manufactured single-cell proteins from a Corynebacterium glutamicum
- 9 October 2024
- Published by Taylor & Francis in CyTA - Journal of Food
- Vol. 22 (1)
Open AccessNutritional properties of pilot-scale manufactured single-cell proteins from a Corynebacterium glutamicum
- Open Access
- 6 September 2024
- Published by Elsevier in Food Bioscience
- Vol. 62
Dietary heme-enriched Corynebacterium extract exerts health benefits by reshaping gut microbiota
- 6 September 2024
- Published by Elsevier in Food Bioscience
- Vol. 62
Open AccessDietary heme-enriched Corynebacterium extract exerts health benefits by reshaping gut microbiota
- Open Access
- 27 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 5824
Development of a Normal Porcine Cell Line Growing in a Heme-Supplemented, Serum-Free Condition for Cultured Meat
A key element for the cost-effective development of cultured meat is a cell line culturable in serum-free conditions to reduce production costs. Heme supplementation in cultured meat mimics the original meat flavor and color. This study introduced a bacterial extract generated from Corynebacterium that was selected for high-heme expression by directed evolution. A normal porcine cell line, PK15, was used to apply the bacterial heme extract as a supplement. Consistent with prior research, we observed the cytotoxicity of PK15 to the heme extract at 10 mM or higher. However, after long-term exposure, PK15 adapted to tolerate up to 40 mM of heme. An RNA-seq analysis of these heme-adapted PK15 cells (PK15H) revealed a set of altered genes, mainly involved in cell proliferation, metabolism, and inflammation. We found that cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1), lactoperoxidase (LPO), and glutathione peroxidase 5 (GPX5) were upregulated in the PK15H heme dose dependently. When we reduced serum serially from 2% to serum free, we derived the PK15H subpopulation that was transiently maintained with 5–10 mM heme extract. Altogether, our study reports a porcine cell culturable in high-heme media that can be maintained in serum-free conditions and proposes a marker gene that plays a critical role in this adaptation process.
- 27 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 5824
Open AccessDevelopment of a Normal Porcine Cell Line Growing in a Heme-Supplemented, Serum-Free Condition for Cultured Meat
A key element for the cost-effective development of cultured meat is a cell line culturable in serum-free conditions to reduce production costs. Heme supplementation in cultured meat mimics the original meat flavor and color. This study introduced a bacterial extract generated from Corynebacterium that was selected for high-heme expression by directed evolution. A normal porcine cell line, PK15, was used to apply the bacterial heme extract as a supplement. Consistent with prior research, we observed the cytotoxicity of PK15 to the heme extract at 10 mM or higher. However, after long-term exposure, PK15 adapted to tolerate up to 40 mM of heme. An RNA-seq analysis of these heme-adapted PK15 cells (PK15H) revealed a set of altered genes, mainly involved in cell proliferation, metabolism, and inflammation. We found that cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1), lactoperoxidase (LPO), and glutathione peroxidase 5 (GPX5) were upregulated in the PK15H heme dose dependently. When we reduced serum serially from 2% to serum free, we derived the PK15H subpopulation that was transiently maintained with 5–10 mM heme extract. Altogether, our study reports a porcine cell culturable in high-heme media that can be maintained in serum-free conditions and proposes a marker gene that plays a critical role in this adaptation process.
- Open Access
- 18 March 2024
- Published by Springer Nature in Bioprocess and Biosystems Engineering
- Vol. 47 (4) , 549-556
Development strategy of non-GMO organism for increased hemoproteins in Corynebacterium glutamicum: a growth-acceleration-targeted evolution
Heme, found in hemoproteins, is a valuable source of iron, an essential mineral. The need for an alternative hemoprotein source has emerged due to the inherent risks of large-scale livestock farming and animal proteins. Corynebacterium glutamicum, regarded for Qualified Presumption of Safety or Generally Recognized as Safe, can biosynthesize hemoproteins. C. glutamicum single-cell protein (SCP) can be a valuable alternative hemoprotein for supplying heme iron without adversely affecting blood fat levels. We constructed the chemostat culture system to increase hemoprotein content in C. glutamicum SCP. Through adaptive evolution, hemoprotein levels could be naturally increased to address oxidative stress resulting from enhanced growth rate. In addition, we used several specific plasmids containing growth-accelerating genes and the hemA promoter to expedite the evolutionary process. Following chemostat culture for 15 days, the plasmid in selected descendants was cured. The evolved strains showed improved specific growth rates from 0.59 h−1 to 0.62 h−1, 20% enhanced resistance to oxidative stress, and increased heme concentration from 12.95 µg/g-DCW to 14.22–15.24 µg/g-DCW. Notably, the putative peptidyl-tRNA hydrolase-based evolved strain manifested the most significant increase (30%) of hemoproteins. This is the first report presenting the potential of a growth-acceleration-targeted evolution (GATE) strategy for developing non-GMO industrial strains with increased bio-product productivity.
- 18 March 2024
- Published by Springer Nature in Bioprocess and Biosystems Engineering
- Vol. 47 (4) , 549-556
Open AccessDevelopment strategy of non-GMO organism for increased hemoproteins in Corynebacterium glutamicum: a growth-acceleration-targeted evolution
Heme, found in hemoproteins, is a valuable source of iron, an essential mineral. The need for an alternative hemoprotein source has emerged due to the inherent risks of large-scale livestock farming and animal proteins. Corynebacterium glutamicum, regarded for Qualified Presumption of Safety or Generally Recognized as Safe, can biosynthesize hemoproteins. C. glutamicum single-cell protein (SCP) can be a valuable alternative hemoprotein for supplying heme iron without adversely affecting blood fat levels. We constructed the chemostat culture system to increase hemoprotein content in C. glutamicum SCP. Through adaptive evolution, hemoprotein levels could be naturally increased to address oxidative stress resulting from enhanced growth rate. In addition, we used several specific plasmids containing growth-accelerating genes and the hemA promoter to expedite the evolutionary process. Following chemostat culture for 15 days, the plasmid in selected descendants was cured. The evolved strains showed improved specific growth rates from 0.59 h−1 to 0.62 h−1, 20% enhanced resistance to oxidative stress, and increased heme concentration from 12.95 µg/g-DCW to 14.22–15.24 µg/g-DCW. Notably, the putative peptidyl-tRNA hydrolase-based evolved strain manifested the most significant increase (30%) of hemoproteins. This is the first report presenting the potential of a growth-acceleration-targeted evolution (GATE) strategy for developing non-GMO industrial strains with increased bio-product productivity.
- 7 December 2022
- Published by Elsevier in Chemistry and Physics of Lipids
- Vol. 250, 105270
Development of skin-permeable flexible liposome using ergosterol esters containing unsaturated fatty acids
- 7 December 2022
- Published by Elsevier in Chemistry and Physics of Lipids
- Vol. 250, 105270
Development of skin-permeable flexible liposome using ergosterol esters containing unsaturated fatty acids
- 1 September 2020
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 139, 109581
Antibacterial activity of emulsions containing unsaturated fatty acid ergosterol esters synthesized by lipase-mediated transesterification
- 1 September 2020
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 139, 109581
Antibacterial activity of emulsions containing unsaturated fatty acid ergosterol esters synthesized by lipase-mediated transesterification
- 28 August 2018
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 187 (3) , 1046-1060
Characterization of Organic Solvent-Tolerant Lipolytic Enzyme from Marinobacter lipolyticus Isolated from the Antarctic Ocean
The Antarctic marine environment provides a good source of novel lipolytic enzymes that possess beneficial properties, i.e., resistance to extreme physical and chemical conditions. We found a lipolytic Escherichia coli colony that was transformed using genomic DNA from Marinobacter lipolyticus 27-A9 isolated from the Antarctic Ross Sea. DNA sequence analysis revealed an open reading frame of lipolytic enzyme gene. The gene translates a protein (LipA9) of 404 amino acids with molecular mass of 45,247 Da. Recombinant LipA9 was expressed in E. coli BL21 (DE3) cells and purified by anion exchange and gel filtration chromatography. The kcat/Km of LipA9 was 175 s−1 μM−1, and the optimum temperature and pH were 70 °C and pH 8.0, respectively. LipA9 had quite high organic solvent stability; it was stable toward several common organic solvents up to 50% concentration. Substrate specificity studies showed that LipA9 preferred a short acyl chain length of p-nitrophenyl ester and triglyceride. Sequence analysis showed that LipA9 contained catalytic Ser72 and Lys75 in S-x-x-K motif, like family VIII esterases. Homology modeling and site-directed mutagenesis studies revealed that Tyr141 and Tyr188 residues were located near the conserved motif and played an important role in catalytic activity.
- 28 August 2018
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 187 (3) , 1046-1060
Characterization of Organic Solvent-Tolerant Lipolytic Enzyme from Marinobacter lipolyticus Isolated from the Antarctic Ocean
The Antarctic marine environment provides a good source of novel lipolytic enzymes that possess beneficial properties, i.e., resistance to extreme physical and chemical conditions. We found a lipolytic Escherichia coli colony that was transformed using genomic DNA from Marinobacter lipolyticus 27-A9 isolated from the Antarctic Ross Sea. DNA sequence analysis revealed an open reading frame of lipolytic enzyme gene. The gene translates a protein (LipA9) of 404 amino acids with molecular mass of 45,247 Da. Recombinant LipA9 was expressed in E. coli BL21 (DE3) cells and purified by anion exchange and gel filtration chromatography. The kcat/Km of LipA9 was 175 s−1 μM−1, and the optimum temperature and pH were 70 °C and pH 8.0, respectively. LipA9 had quite high organic solvent stability; it was stable toward several common organic solvents up to 50% concentration. Substrate specificity studies showed that LipA9 preferred a short acyl chain length of p-nitrophenyl ester and triglyceride. Sequence analysis showed that LipA9 contained catalytic Ser72 and Lys75 in S-x-x-K motif, like family VIII esterases. Homology modeling and site-directed mutagenesis studies revealed that Tyr141 and Tyr188 residues were located near the conserved motif and played an important role in catalytic activity.
- 28 February 2017
- Published by Korean Society for Microbiology and Biotechnology in Journal of Microbiology and Biotechnology
- Vol. 27 (2) , 289-296
Cadaverine Production by Using Cross-Linked Enzyme Aggregate of Escherichia coli Lysine Decarboxylase
Lysine decarboxylase (CadA) converts L-lysine into cadaverine (1,5-pentanediamine), which is an important platform chemical with many industrial applications. Although there have been many efforts to produce cadaverine through the soluble CadA enzyme or Escherichia coli whole cells overexpressing the CadA enzyme, there have been few reports concerning the immobilization of the CadA enzyme. Here, we have prepared a cross-linked enzyme aggregate (CLEA) of E. coli CadA and performed bioconversion using CadACLEA. CadAfree and CadACLEA were characterized for their enzymatic properties. The optimum temperatures of CadAfree and CadACLEA were 60°C and 55°C, respectively. The thermostability of CadACLEA was significantly higher than that of CadAfree. The optimum pH of both enzymes was 6.0. CadAfree could not be recovered after use, whereas CadACLEA was rapidly recovered and the residual activity was 53% after the 10th recycle. These results demonstrate that CadACLEA can be used as a potential catalyst for efficient production of cadaverine.
- 28 February 2017
- Published by Korean Society for Microbiology and Biotechnology in Journal of Microbiology and Biotechnology
- Vol. 27 (2) , 289-296
Cadaverine Production by Using Cross-Linked Enzyme Aggregate of Escherichia coli Lysine Decarboxylase
Lysine decarboxylase (CadA) converts L-lysine into cadaverine (1,5-pentanediamine), which is an important platform chemical with many industrial applications. Although there have been many efforts to produce cadaverine through the soluble CadA enzyme or Escherichia coli whole cells overexpressing the CadA enzyme, there have been few reports concerning the immobilization of the CadA enzyme. Here, we have prepared a cross-linked enzyme aggregate (CLEA) of E. coli CadA and performed bioconversion using CadACLEA. CadAfree and CadACLEA were characterized for their enzymatic properties. The optimum temperatures of CadAfree and CadACLEA were 60°C and 55°C, respectively. The thermostability of CadACLEA was significantly higher than that of CadAfree. The optimum pH of both enzymes was 6.0. CadAfree could not be recovered after use, whereas CadACLEA was rapidly recovered and the residual activity was 53% after the 10th recycle. These results demonstrate that CadACLEA can be used as a potential catalyst for efficient production of cadaverine.